DAVE vs. ANAB
DAVE (Dave Inc.) and ANAB (AnaptysBio, Inc.) are both stocks. DAVE operates in Software - Application (Technology), while ANAB operates in Biotechnology (Healthcare). Over the past 5 years, DAVE returned 1.92%/yr vs 29.07%/yr for ANAB. At a 0.15 correlation, their price movements are largely independent.
Performance
DAVE vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DAVE achieves a 57.50% return, which is significantly lower than ANAB's 95.39% return.
DAVE
- 1D
- 8.04%
- 1M
- 23.41%
- YTD
- 57.50%
- 6M
- 52.13%
- 1Y
- 39.69%
- 3Y*
- 313.84%
- 5Y*
- 1.92%
- 10Y*
- —
ANAB
- 1D
- 5.81%
- 1M
- 13.44%
- YTD
- 95.39%
- 6M
- 89.07%
- 1Y
- 321.56%
- 3Y*
- 66.59%
- 5Y*
- 29.07%
- 10Y*
- —
DAVE vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DAVE Dave Inc. | 57.50% | 154.73% | 936.61% | -9.64% | -97.17% | 4.59% |
ANAB AnaptysBio, Inc. | 95.39% | 266.16% | -38.19% | -30.88% | -10.82% | 47.18% |
Correlation
The correlation between DAVE and ANAB is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Apr 26, 2021 | 0.15 |
Fundamentals
DAVE:
$5.02B
ANAB:
$1.81B
DAVE:
$15.54
ANAB:
-$0.91
DAVE:
9.16
ANAB:
8.01
DAVE:
24.64
ANAB:
142.14
DAVE:
$551.52M
ANAB:
$232.39M
DAVE:
$427.68M
ANAB:
$245.59M
DAVE:
$165.95M
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DAVE vs. ANAB — Risk / Return Rank
DAVE
ANAB
DAVE vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dave Inc. (DAVE) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DAVE | ANAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.84 | ||
| Sortino ratioReturn per unit of downside risk | -3.02 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.57 | -0.42 |
| Calmar ratioReturn relative to maximum drawdown | 0.98 | 10.92 | -9.94 |
| Martin ratioReturn relative to average drawdown | 1.75 | 25.61 | -23.86 |
Loading charts...
Drawdowns
DAVE vs. ANAB - Drawdown Comparison
The maximum DAVE drawdown since its inception was -99.01%, which is greater than ANAB's maximum drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for DAVE and ANAB.
Loading charts...
Drawdown Indicators
| DAVE | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.01% | -92.08% | -6.93% |
Max Drawdown (1Y)Largest decline over 1 year | -44.67% | -28.15% | -16.52% |
Max Drawdown (3Y)Largest decline over 3 years | -44.67% | -69.32% | +24.65% |
Max Drawdown (5Y)Largest decline over 5 years | -99.01% | -69.32% | -29.69% |
Current DrawdownCurrent decline from peak | -23.80% | -26.31% | +2.51% |
Average DrawdownAverage peak-to-trough decline | -68.65% | -64.51% | -4.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.86% | 11.99% | +12.87% |
Volatility
DAVE vs. ANAB - Volatility Comparison
Dave Inc. (DAVE) has a higher volatility of 20.99% compared to AnaptysBio, Inc. (ANAB) at 13.91%. This indicates that DAVE's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DAVE | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.99% | 13.91% | +7.08% |
Volatility (6M)Calculated over the trailing 6-month period | 50.40% | 46.97% | +3.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.72% | 69.33% | +4.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.74% | 65.40% | +33.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.08% | 75.37% | +21.71% |
Dividends
DAVE vs. ANAB - Dividend Comparison
Neither DAVE nor ANAB has paid dividends to shareholders.
Financials
DAVE vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between Dave Inc. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DAVE and ANAB have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DAVE has higher volatility (20.99%) compared to ANAB (13.91%). In terms of maximum drawdown, DAVE dropped -99.01% vs ANAB's -92.08%.
ANAB currently has the higher Sharpe Ratio (4.43 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DAVE and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer